Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

GDT

Guidant (GDT)

Guidant Corp
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:GDT
DateHeureSourceTitreSymboleSociété
21/04/200619h02PR Newswire (US)Boston Scientific Completes Combination with GuidantNYSE:GDTGuidant Corp
21/04/200615h12PR Newswire (US)Abbott Completes Acquisition of Guidant Vascular BusinessNYSE:GDTGuidant Corp
20/04/200615h00PR Newswire (US)Boston Scientific Receives FTC Antitrust Approval for its Combination with GuidantNYSE:GDTGuidant Corp
12/04/200601h05PR Newswire (US)Standard & Poor's Announces Changes to U.S. IndicesNYSE:GDTGuidant Corp
11/04/200619h59PR Newswire (US)Boston Scientific Receives European Commission's Antitrust Clearance for Guidant TransactionNYSE:GDTGuidant Corp
05/04/200623h34PR Newswire (US)Boston Scientific Signs Agreement Resolving All Outstanding Antitrust Issues With FTC Staff on Guidant TransactionNYSE:GDTGuidant Corp
05/04/200623h25Business WireGuidant Announces Preliminary First Quarter 2006 SalesNYSE:GDTGuidant Corp
31/03/200619h03PR Newswire (US)Boston Scientific and Guidant Shareholders Each Approve CombinationNYSE:GDTGuidant Corp
29/03/200615h00Business WireGuidant to Temporarily Suspend XIENCE V Supply; Company Expects European Launch of XIENCE V in Third Quarter 2006NYSE:GDTGuidant Corp
24/03/200600h10PR Newswire (US)Boston Scientific Makes Antitrust Commitments To European CommissionNYSE:GDTGuidant Corp
21/03/200613h30Business WireGuidant Receives Independent Panel Report and Recommendations; Panel Chaired by Dr. Myerburg, an Internationally Recognized LeaNYSE:GDTGuidant Corp
21/03/200613h25PR Newswire (US)Independent Panel Commissioned by Guidant Issues Report and RecommendationsNYSE:GDTGuidant Corp
20/03/200615h30PR Newswire (US)Institutional Shareholder Services Recommends That Shareholders of Boston Scientific and Guidant Approve CombinationNYSE:GDTGuidant Corp
17/03/200615h00Business WireGuidant Announces Enrollment of First Patient in Landmark Carotid Artery Stenting Study; 10,000-Patient Study Aims to Further UNYSE:GDTGuidant Corp
16/03/200620h30Business WireGuidant to Expand Southern California Facilities; Drug Eluting and Carotid Stents, Emerging Therapies Drive ExpansionNYSE:GDTGuidant Corp
15/03/200620h29Business WireGuidant Completes Enrollment in Randomized U.S. Portion of Drug Eluting Stent Pivotal Trial; Large-Scale Trial Evaluating SafetNYSE:GDTGuidant Corp
14/03/200621h58Business WireGuidant Announces Updated and Positive Results of Real-World Carotid Artery Stenting Study; Results from 2,500 Patients SuggestNYSE:GDTGuidant Corp
13/03/200615h00Business WireGuidant Initiates Voluntary Worldwide Physician Communication Regarding Implantable Cardiac DefibrillatorsNYSE:GDTGuidant Corp
10/03/200619h00Business WireR. Frederick McCoy, Jr., Elects Early Retirement from GuidantNYSE:GDTGuidant Corp
09/03/200618h00Business WireGuidant Launches Innovative Cobalt Chromium Biliary Stent; RX HERCULINK ELITE Biliary Stent System Provides Superb DeliverabiliNYSE:GDTGuidant Corp
09/03/200615h02Business WireGuidant Announces Enrollment of First Patient in Clinical Trial of the World's First Fully Bioabsorbable Drug Eluting CoronaryNYSE:GDTGuidant Corp
06/03/200617h14PR Newswire (US)Seven Summits Research Releases Comments on GM, RIMM, CELG, GDT, and LEXRNYSE:GDTGuidant Corp
03/03/200600h11PR Newswire (US)Boston Scientific and Guidant Proposed Merger Registration Statement Declared EffectiveNYSE:GDTGuidant Corp
23/02/200618h09PR Newswire (US)Boston Scientific Files Notification with European CommissionNYSE:GDTGuidant Corp
23/02/200614h31Business WireGuidant Announces Completion of FDA Inspection of St. Paul Facilities; Company Reports One Inspection Observation and ReiteratesNYSE:GDTGuidant Corp
07/02/200614h00Business WireTheregen Announces Equity Investment from Guidant Corporation to Develop Anginera(TM) Epicardial PatchNYSE:GDTGuidant Corp
06/02/200616h32PR Newswire (US)Boston Scientific Files Hart-Scott-Rodino Pre-Merger NotificationNYSE:GDTGuidant Corp
30/01/200620h02Business WireGuidant Receives European Approval for Drug Eluting Coronary Stent; Company Achieves CE Mark Approval Ahead of Schedule; XIENCENYSE:GDTGuidant Corp
27/01/200614h30Business WireGuidant Reports Fourth Quarter Sales of $828 Million; Full Year 2005 Sales of $3.55 Billion; Earnings from Continuing OperationsNYSE:GDTGuidant Corp
25/01/200613h02PR Newswire (US)Boston Scientific and Guidant Announce Signing of Merger Agreement Valued at $27 BillionNYSE:GDTGuidant Corp
 Showing the most relevant articles for your search:NYSE:GDT